Physician profile
Michael Moua
NPI 1811299928
$1,398.80
in general payments reported to CMS, 2019-2025
9 companies · $138 in 2025
The $138 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $369 · 2021: $381 · 2022: $68.44 · 2023: $132 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $660.62 | 2019-2022 | |
| Gilead Sciences, INC. | $556.27 | 2019-2025 | |
| Cipher Pharmaceuticals US LLC | $43.53 | 2025 | Natroba, Spinosad |
| Glaxosmithkline, LLC. | $38.93 | 2023-2025 | Shingrix, Bexsero, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $23.42 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.56 | 2025 | |
| Novo Nordisk INC | $19.90 | 2019 | |
| Hologic Sales and Service, LLC | $17.79 | 2023 | Aptima |
| Merck Sharp & Dohme LLC | $15.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.